Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Bin Su
Introduction: Bin Su is a notable inventor based in Columbus, OH, who has made significant strides in the field of cancer research. His work primarily focuses on developing compounds that can effectively suppress aromatase activity, which is crucial in the treatment of certain types of cancer, particularly breast cancer.
Latest Patents: Bin Su holds a patent for "Sulfonanilide analogs as selective aromatase modulators (SAMs)." This patent describes compounds and methods that suppress aromatase activity expression in cancer cells. The compounds are characterized by a specific formula where various groups can be substituted, including alkyl, cycloalkyl, haloalkyl, aryl, and others. The patent also details small molecule selective aromatase inhibitors with a molecular weight of less than 500 g/mol, and methods for administering these inhibitors to patients in need of treatment.
Career Highlights: Bin Su is affiliated with The Ohio State University, where he contributes to research and development in the field of pharmacology and cancer treatment. His innovative approach to creating selective aromatase inhibitors has the potential to improve therapeutic outcomes for patients suffering from breast cancer.
Collaborations: Bin Su has collaborated with esteemed colleagues such as Robert Brueggemeier and Edgar S Diaz-Cruz, enhancing the research efforts in the domain of cancer therapeutics.
Conclusion: Bin Su's contributions to the field of cancer research through his innovative patents and collaborations highlight the importance of continued research and development in medical science. His work exemplifies the potential for innovation to lead to significant advancements in treatment options for cancer patients.